PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy as First-line Treatment for Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis

Immunotherapy combined with chemotherapy has recently changed the first-line treatment of several cancers. We performed a systematic review and meta-analysis to assess the efficacy and safety of programmed cell death 1 (PD-1) inhibitor plus chemotherapy as a first-line treatment for advanced esophag...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yao, Xu, Mengli, Guan, Lulu, Yang, Yalan, Chen, Yu, Yang, Yuanyuan, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087869/
https://www.ncbi.nlm.nih.gov/pubmed/35467579
http://dx.doi.org/10.1097/CJI.0000000000000420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087869/
https://www.ncbi.nlm.nih.gov/pubmed/35467579
http://dx.doi.org/10.1097/CJI.0000000000000420

Ejemplares similares